Document:

EXHIBIT 10.3

[GRAPHIC OMITTED]

November 1, 2005

Walter W. Witoshkin
QuantRx Biomedical Corporation
(Formerly A-Fem Medical
Corporation)
321 Norristown Road Suite 230
Ambler, PA 19002

Dear Mr. Witoshkin:

The purpose of this letter agreement (the "Agreement") is to set forth the
terms and' conditions pursuant to which Dawson James Securities, Inc., ("Dawson
James") shall introduce QuantRx Biomedical Corporation (the "Company") to one or
more investors in connection with the proposed offering (the "Offering") of
securities (the "Securities") of the Company. The terms of such Offering and the
Securities shall be mutually agreed upon by the Company and the investor(s).
Dawson James's engagement under this Agreement shall be non-exclusive. The
identities of the investors to which Dawson James introduces the Company shall
be proprietary.. information of Dawson James and shall not be divulged to third
parties by the Company, nor used by the Company outside the scope of Dawson
James's engagement as described herein, other than as required by applicable
law.

In consideration of the services rendered by Dawson James under this Agreement,
the Company agrees to pay Dawson James the following fees and other
compensation: A cash fee payable immediately upon the dosing of any portion of
any Financing (including without limitation the Offering) equal to 8% of the
aggregate capital raised by Dawson James Securities and warrants to purchase 8%
of the units sold to the investor(s) by Dawson James Securities.

This Agreement shall be governed by and construed in accordance with the laws of
the State of Florida, without regard to conflicts of law principles. Any dispute
arising out of this Agreement shall be adjudicated in the courts of the State
of

<PAGE>

Florida or in the federal courts sitting in the Southern District of Florida,
and each of the parties hereto agrees that service of process upon it by
registered or certified mail at its address set forth herein shall be deemed
adequate and lawful. The Company shall indemnify Dawson James in accordance with
the terms of the Securities Purchase Agreement among the Company and the
purchasers. The Company acknowledges and agrees that Dawson James is not and
shall not be construed as a fiduciary of the Company and shall have no duties or
liabilities to the equity holders or the creditors of the Company or any other
person by virtue of this Agreement or the retention of Dawson James hereunder,
all of which are hereby expressly waived.

     This Agreement constitutes the entire understanding and agreement between
the parties hereto with respect to its subject matter and there are no
agreements or understandings with respect to the subject matter hereof which are
not contained in this Agreement. This Agreement may be modified only in writing
signed by the party to be charged hereunder.

     If the foregoing correctly sets forth our agreement, please confirm this by
signing and returning to us the duplicate copy of this letter.

Thank you
Dawson James Securities, Inc.

By: /s/Robert D. Keyser, Jr.
------------------------------------------
Robert D. Keyser Jr.
CEO

By: /s/Al Poliak
    --------------------------------------
    Al Poliak, President

Agreed to and accepted as of the date first written above:

QuantRx Biomedical Corporation

By: /s/Walter Witoshkin
------------------------------------------
Witoshkin President, CEOEXHIBIT 10.4

[GRAPHIC OMITTED]     Main Office
                      925 South Federal Highway
                      GO" Floor
                      Boca Raton, FL 33432
                      Toll Free: 1-866-928-0928
                      Telephone: 561-391-5555                  Fax: 561-391-3757

     Member NASD/SIPC

April 13, 2005

Mr. William I'I. Fleming, Ph. D
Vice Chairman & COO
A-Fem Medical Corporation
14889 Tualatin-Sherwood Road
Ste. 405
Sherwood, OR 97140

RE: Private Placement of Securities for A-Fem Medical Corporation

Dear Mr. Fleming:

This binding letter of intent confirms our understanding that A-Fem Medical
Corporation (together with its affiliates and subsidiaries, "A-Fem Medical
Corporation " or the "Company") has engaged Dawson James Securities, Inc.
(together with its affiliates and subsidiaries, "Dawson James") to act as a
"non-exclusive" placement agent of the Company ("Placement Agent") in connection
with a best efforts private placement offering of the Company's Common Stock and
Warrants (the "Placement"). This letter will confirm our acceptance and set
forth the terms of the engagement agreed to between Dawson lames and the
Company.

         1. Information. In connection with the Placement Agent's activities
hereunder, the Company will furnish Dawson James with all material and
information regarding the business and financial condition of the Company,
including but not limited to last three years financial statements, financial
projections, material conaacts. all documents evidencing indebtedness, sales and
marketing plans, labor and executive compensation agreements, environmental
matters, tax matters, intellectual property matters, litigation matters and such
other data, information or files that may be material to the business of the
Company or otherwise requested by Dawson James (the "Information"). The Company
will cooperate with Dawson James in furnishing all Information as may be
requested by Dawson James from time to time and will provide access to the
officers, directors, employees, accountants, counsel and other professionals of
the Company to the extent Dawson James deems appropriate. The Company represents
and warrants that all Information, including but not limited to the Company's
financial statements, will be complete and correct in all material respects and
will not contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein not misleading.
The Company recognizes and confirms that the non-exclusive Placement Agent: (i)
will use and rely primarily on the Information and on information available from
generally recognized public sources in performing the services contemplated by
this letter without having independently verified the same; (ii) is authorized
as the Company's financial advisor and placement agent to transmit to any
prospective investor a copy or copies, forms of purchase agreements and any
other legal documentation supplied to the Placement Agent for transmission to
any prospective investor by or on behalf of the Company or by any of the
Company's officers, representatives or agents, in connection with the
performance of the Placement Agent's services hereunder or any transaction
contemplated hereby; (iii) does not assume responsibility for the accuracy or
completeness of the Information and such other information; (iv) will not make
an appraisal of any assets of the Company; and (v) retains the right to continue
to perform due diligence during the course of the engagement. Accordingly, the
Company agrees that Dawson James assumes no responsibility for the accuracy and
completeness of the Information. The Placement Agent agrees to keep the
Information confidential and will not make use thereof, except in connection
with services hereunder for the Company, unless; (i) disclosure is required by
law or requested by any government, regulatory or self-regulatory agency or body
in which event the Placement Agent will provide the Company with reasonable
advance notice of such proposed disclosure; (ii) any information is or becomes
generally available to the public; or (iii) any Information was or becomes
available to the Placement Agent on a non-confidential basis from a source other
than the Company or any of its representatives.

         2. Compensation. As compensation for services rendered and to be
rendered hereunder by Dawson James, the Company agrees to pay Dawson James as
follows;

<PAGE>

              a) An amount in cash equal to ten percent (10%) of the principal
amount of any Placement placed and/or commined by any investor originating from
a relationship with the Company and payable at the time of each closing of the
Financing ("Placement Fee").

              b) The Company will issue to Dawson James warrants to purchase
shares of the Company's Common Stock equal to ten percent (10%) of the number of
common shares ("Shares") issued in the Placement. Such Warrants will be issued
pursuant to a Warrant Agreement to be signed by the Company and Dawson James or
any assignee of Dawson James, which agreement shall provide, among other things,
that the Warrants shall be exercisable at an exercise price equal to the price
at which the Shares are sold to investors in the Placement, shall expire seven
(7) years from the date of first closing, include registration rights at the
time that all shares issued in this Placement are registered, and provisions for
cashless exercise, and such other terms as are normal and customary for Warrants
of this type.

              c) Notwithstanding any termination of this Agreement pursuant to
the terms hereof or otherwise, if on or before the twenty four (24) month
anniversary of the final closing of the Placement, the Company enters into a
definitive commitment relating to a Placement (or any portion thereof), capital
raise, or consummates a Placement with any party, or the Company enters into a
defmitive commitment relating to a Placement (or any portion thereof) with any
financing source introduced to the Company by Dawson James, the Company agrees
to pay Dawson James all such compensation pursuant to the terms of Section 2
'Compensation" of this Agreement.

         3. Certain Placement Procedures. The Company and the Placement Agent
each represents to the other that it has not taken, and the Company and the
Placement Agent each agrees with the other that it will not take any action,
directly or indirectly, so as to cause the Placement to fail to be entitled to
rely upon the exemption from registration afforded by Section 4(2) of the
Securities Act of 1933, as amended (the "Act"). In effecting the Placement, the
Company and the Placement Agent each agrees to comply in all material respects
with applicable provisions of the Act and any regulations thereunder and any
applicable state laws and requirements. The Company agrees that any
representations and warranties made by it to any investor in the Placement shall
be deemed also to be made to the Placement Agent for its benefit. The Company
agrees that it shall cause any opinion of its counsel delivered to any investors
in the Placement also to be addressed and delivered to the Placement Agent, or
to cause such counsel to deliver to the Placement Agent a letter authorizing it
to rely upon such opinion. Upon completion of the Placement, all shares placed
by the Placement Agent will be deposited into a Dawson James client account for
the benefit of each investor.

         4. Termination; Survival of Provisions. This Agreement may be
terminated by the Placement Agent or the Company at any time upon thirty (30)
days prior written notice to the other parry, provided, however, that: (a) any
termination or completion of Dawson James's engagement hereunder shall not
affect the Company's obligation to indemnity Dawson Janus as provided in the
separate letter agreement referred to above and (b) any termination by the
Company of Dawson James' engagement hereunder shall not affect the Company's
obligation to pay fees to the extent provided for in Section 2(c) herein, and
any unpaid amounts thereunder shall be accelerated and be immediately due and
payable to Dawson James on the termination date; and (c) any termination by
Dawson James of Dawson James's engagement hereunder shall not affect the
Company's obligation to pay fees and reimburse the expenses accruing prior to
such termination to the extent provided for herein. All such fees and
reimbursements due the Placement Agent, shall be paid to the Placement Agent on
or before the Termination Date (in the event such fees and reimbursements are
earned or owed as of the Termination Date) or upon the closing of the Placement
or any applicable portion thereof (in the event such fees are due pursuant to
the terms of Section 2 "Compensation" hereof).

         5. Governing Law; Amendment; Headings. This Agreement and all
controversies arising from and relating to performance under this agreement
shall be governed by and construed in accordance with the laws of the State of
Florida, without giving effect to such state's rules concerning conflicts of
laws. This Agreement may not be modified or amended except in writing duly
executed by the parties hereto. The section headings in this Agreement have been
inserted as a matter of convenience of reference and are not pan of this
Agreement.

         6. Nondisclosure of Confidential Information. Dawson James and the
Company mutually agree that they will not disclose any confidential information
received from the other party to others except with the wntten permission of the
other party or as such disclosure may be required by law. Dawson James has been
retained under this agreement as an independent contractor with duties owed
solely to the Company. The advice, written or oral, rendered by Dawson James
pursuant to this Agreement is intended solely for the benefit and use of the
Company in considering the matters to which this agreement relates, and the
Company agrees that such advice may not be relied upon by any other person, used
for any other purpose, reproduced, disseminated, or referred to at any time, in
any manner or for any purpose, nor shall any public references to Dawson James
be made by the Company, without the prior written consent of Dawson James, which
consent shall not be unreasonably withheld.

         7. Successors and Assigns. The benefits of this Agreement shall inure
to the parities hereto, their respective successors and assigns and to the
indemnified parties hereunder and their respective successors and assigns, and
the obligations and

<PAGE>

liabilities assumed in this Agreement shall be binding upon the parties hereto
and their respective successors and assigns. Notwithstanding anything contained
herein to the contrary, neither the Placement Agent nor the Company shall assign
to an unaffiliated third patty any of its obligations hereunder.

         8. Press Announcements. The Company agrees that Dawson James shall,
upon a successful transaction, have the right to place advertisements in
financial and other newspapers and journals at its own expense describing its
services to the Company hereunder.

         9. Expenses. The Company will pay all of its costs relating to the
Placement contemplated hereby, including, without limitation, audit expenses,
issuance costs and taxes, counsel fees for the preparation of the Offering
Documents, filing fees and disbursements of counsel relating to the
qualification of the offered securities under federal securities laws, and legal
fees and expenses of counsel in connection with qualifying the offered securines
under state blue sky laws. To the extent required by law, the Company shall
qualify the offered securities for offer and sale in those jurisdictions
designated by Dawson James. The Company's counsel shall be responsible for state
blue sky securities laws compliance by the Company.

         10. Conditions of the Obligations of Dawson James.

         The obligations of Dawson James to act as agent hereunder, to find
purchasers for the Placement, and to attend and to deliver documents at Closing
shall be subject to the following conditions:

              (a) Between the date hereof and Closing, the Company and its
subsidiaries shall not have sustained any loss on account of fue, explosion,
flood, accident, calamity or other cause, of such character as materially
affects the business or property of the Company and its subsidiaries, whether or
not such loss is covered by insurance.

              (b) Between the date hereof and Closing, there shall be no
litigation instituted or threatened against the Company or any subsidiary (other
than as set forth in the Offering Document) and there shall be no proceeding
instituted or threatened before or by any federal or state commission,
regulatory body or administrative agency or other governmental body, domestic or
foreign, wherein an unfavorable ruling, decision or finding would materially
adversely affect the business, franchises, licenses, permits, operations or
financial condition or income of the Company.

              (c) Except as contemplated herein or as set forth in the Offering
Document, during the period subsequent to the date hereof, and prior to Closing,
the Company and each subsidiary: (i) shall have conducted its business in the
usual and ordinary manner as the same was being conducted on the date hereof,
and (ii) except in the ordinary course of its business, the Company and each
subsidiary shall not have incurred any liabilities or obligations (direct or
contingent), or disposed of any assets, or entered into any material transaction
or suffered or experienced any substantially adverse change in its condition,
financial or otherwise, or in its working capital position. At Closing, the
capitalization of the Company shall be substantially the same as set forth in
the Offering Document.

              (d) The authorization for the issuance and delivery of the offered
securities in the Placement and the Offering Document and related materials, and
for the execution and delivery of this Agreement, and all other legal matters
incident thereto, shall be reasonably satisfactory in all respects to counsel
for Dawson James.

              (e) The representations and warranties of the Company made in this
Agreement or in any document or certificate delivered to Dawson James pursuant
hereto shall be true and correct on and as of the Closing with the same force
and effect as though such representations and warranties have been made on and
as of the Closing.

              (f)  The Company shall have performed and complied in all
material respects with all covenants, terms and agreements to be performed and
complied with by the Company on or before the Closing.

              (g) The Company shall have provided such certificates as Dawson
James shall reasonably request.

              (h) The Company and its President shall provide certificates to
Dawson James cenifying that the proceeds of the Placement will be used in
accordance with the uses designated in "Use of Proceeds" in the Offering
Document.

              (i) The Company shall have furnished a "Cold Comfort" letter on
and as of the Closing, in each case describing procedures carried our to a date
within five (5) days of the date of the leuer, from independent public
accountants for the Company, substantially in the form approved by Dawson James.

<PAGE>

         11.      Indemnification

                 (a) The Company agrees to indemnify and hold harmless DAWSON
 JAMES and each person, if any, who controls DAWSON JAMES within the meaning of
 the 1933 Act or the 1934 Act (together. the "Acts"), the DAWSON JAMES'
 affiliated entities, partners, employees, legal counsel and agents (the "DJ
 Indemnified Parties") against any losses, claims, damages, obligations,
 penalties, judgments, awards, liabilities, costs, expenses and disbursements
 (and any and all actions, suits, proceedings and investigations in respect
 thereof and any and all legal and other costs, expenses and disbursements in
 giving testimony or furnishing documents in response to a subpoena or
 otherwise), joint or several, to which DAWSON JAMES or such person may be
 subject, under the Acts or otherwise. including, without limitation, the costs,
 expenses and disbursements, as and when incurred, of investigating, preparing
 or defending any such action, suit, proceeding or investigation (whether or not
 in connection with Iitigation in which the DAWSON JAMES is a party), directly
 or indirectly, caused by, relating to, based upon, arising out of. or in
 connection with (i) the violation or breach of any representation, warranty or
 covenant or agreement of the Company set forth in this Agreement or in any
 instrument, document, agreement or certificate delivered by the Company in
 connection herewith; (ii) any untrue statement or omission or any alleged
 untrue statement or omission in the Offering Document or selling material,
 excluding information contained in or omitted from the Offering Document or
 selling material in reliance upon, and in conformity with, information
 furnished to the Company by DAWSON JAMES or any Participating Broker-Dealer
 specifically for use in preparation of the Offering Document or selling
 material, as the case may be: (iii) any information provided by or on behalf of
 Company in order to qualify or exempt the Offered Securities for sale in any
 jurisdiction; or (iv) the failure of the Company to comply with the provisions
 of the Acts and the regulations thereunder, including Regulation D; and will
 reimburse the DJ Indemnified Parties for any legal or other expenses reasonably
 incurred by the DJ Indemnified Parries in connection with investigation of or
 defending against any such loss, claim, expense, damage, liability, (or actions
 in respect thereof); provided, however, that the Company shall not be required
 to indemnify the DJ Indemnified Parries for any payment made to any claimant in
 settlement of any suit or claim unless such payment is agreed to by the Company
 (which agreement shall not be unreasonably withheld) or by a coup having
 jurisdiction of the controversy. This inndemnity agreement shall remain in full
 force and effect notwithstanding any investigation trade by DAWSON JAMES or on
 DAWSON JAMES' behalf, shall survive consummation of the sale of the Offered
 Securities hereunder and all be in addition to any liability which the Company
 may otherwise have.

              (b) DAWSON JAMES agrees to indemnify and hold harmless the Company
and each person, if any, who controls the Company within the meaning of the
Acts, Company's affiliated entities, partners, employees, legal counsel and
agents (the "Company Indemnified Parties") against any losses, claims, expenses,
damages or liabilities (or actions in respect thereof), joint or several, to
which the Company Indemnified Parties or any such controlling person may become
subject, under the Acts or otherwise, insofar as such losses, claims, expenses,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon any untrue statement or omission .or any alleged untrue statement or
omission in the Offering Document contained in or omitted from the Offering
Document in reliance on, and in conformity with, information furnished to the
Company by DAWSON JAMES or any Participating Broker-Dealer or either of them
specifically for use in preparation of the Offering Document or selling
material, as the case may be; and will reimburse the Company Indemnified Parties
for any legal or other expenses reasonably incurred by them in connection with
investigating or defending against any such loss, claim, expense, damage,
liability, (or actions in respect thereof); provided, however, that DAWSON JAMES
shall not be required to indemnify the Company Indemnified Parties for any
payment made to any claimant in settlement of any suit or claim unless such
payment is approved by a court having jurisdiction over the controversy or
DAWSON JAMES agrees to such settlement (which agreement shall not be
unreasonably withheld): and provided further that DAWSON JAMES shall not be
liable under this Section 11(b) for any losses, claims, expenses, damages or
liabilities arising out of any act or failure to act on the pan of any other
person except DAWSON JAMES, its partners, employees and agents (including
registered representatives) or any Participating Broker-Dealer. This indemnity
agreement shell remain in full force and effect notwithstanding any
investigation made by or on behalf of the Company and shall survive consummation
of the sale of the Offered Securities hereunder and the termination of this
Agreement. and shall be in addition to any liability which DAWSON JAMES may
otherwise have. Notwithstanding the foregoing, in no event shall the amount that
the DAWSON JAMES is required to indemnify the Company Indemnified Parties,
exceed in the aggregate the compensation received by the DAWSON JAMES hereunder,
except in the case of fraud on the pan of the DAWSON JAMES.

              (c) The indemnified parry shall noti fy the indemnifying party in
writing promptly after the sons or other first legal process giving information
of the nature of any and all claims which have been served upon the indemnified
parry. In case any action is brought against any indemnified parry upon any such
claim the indemnifying party shall be entitled to participate at its own expense
in the defense, or if it so elects, in accordance with arrangements satisfactory
to any other indemnifying arty or parties similarly notified, to assume the
defense thereof, with counsel who shall be satisfactory to such indemnified
party and other indemnified parties who are defendants in such action; and after
notice from the indemnifying parry to such indemnified party of its election so
to assume the defense thereof and the retaining of such counsel by the
indemnifying party, the indemnifying party shall not be liable to such
indemnified party under this Section 11 for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense
thereof, other than the reasonable costs of investigation, unless the
indemnified party shall have reasonably concluded that there are or may be
defenses available to it which are different from or in addition to those
available to the indemnifying party (in which case the indemnifying party shall
not have the right to direct the defense of such action on behalf of the
indemnified parry), in any of which circumstances such expenses shall be borne
by the indemnifying parry.

        12. Counterparts. For the convenience of the patties, this Agreement may
be executed in any number of counterparts, each of which shall be, and shall be
deemed to be, an original instrument, but all of which taken together shall
constitute one and the same Agreement.

<PAGE>

        If the terms of our engagement as set forth in this letter are
satisfactory to you, please sign and date the enclosed copy of this letter and
indemnification form and send back to us. If this agreement is not executed by
both parties within five (5) days from its date, it shall cease to be a valid
offer to assist and represent the Company.

                                    Very truly yours,

                                    By: /s/Robert D. Keyser Jr.
                                        ----------------------------------------
                                        Robert D. Keyser Jr
                                        Chief Executive Officer
                                        Dawson James Securities
                                        (a division of Viewtrade Financial)

ACCEPTED AND AGREED TO: as of the date hereof:

                                    For:

                                    William H. Fleming, Ph. D
                                    --------------------------------------------
                                    By: William H. Fleming, Ph. D

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]